Systems Biology in ELIXIR: modelling in the spotlight

Author:

Martins dos Santos Vitor,Anton MihailORCID,Szomolay Barbara,Ostaszewski Marek,Arts Ilja,Benfeitas Rui,Dominguez Del Angel VictoriaORCID,Ferk Polonca,Fey Dirk,Goble Carole,Golebiewski MartinORCID,Gruden Kristina,Heil Katharina F.ORCID,Hermjakob Henning,Kahlem PascalORCID,Klapa Maria I.ORCID,Koehorst Jasper,Kolodkin AlexeyORCID,Kutmon MartinaORCID,Leskošek Brane,Moretti SébastienORCID,Müller Wolfgang,Pagni Marco,Rezen Tadeja,Rocha Miguel,Rozman Damjana,Šafránek DavidORCID,Sheriff Rahuman S. MalikORCID,Suarez Diez MariaORCID,Van Steen Kristel,Westerhoff Hans VORCID,Wittig UlrikeORCID,Wolstencroft KatherineORCID,Zupanic AnzeORCID,Evelo Chris T.ORCID,Hancock John M.ORCID

Abstract

In this white paper, we describe the founding of a new ELIXIR Community - the Systems Biology Community - and its proposed future contributions to both ELIXIR and the broader community of systems biologists in Europe and worldwide. The Community believes that the infrastructure aspects of systems biology - databases, (modelling) tools and standards development, as well as training and access to cloud infrastructure - are not only appropriate components of the ELIXIR infrastructure, but will prove key components of ELIXIR’s future support of advanced biological applications and personalised medicine. By way of a series of meetings, the Community identified seven key areas for its future activities, reflecting both future needs and previous and current activities within ELIXIR Platforms and Communities. These are: overcoming barriers to the wider uptake of systems biology; linking new and existing data to systems biology models; interoperability of systems biology resources; further development and embedding of systems medicine; provisioning of modelling as a service; building and coordinating capacity building and training resources; and supporting industrial embedding of systems biology. A set of objectives for the Community has been identified under four main headline areas: Standardisation and Interoperability, Technology, Capacity Building and Training, and Industrial Embedding. These are grouped into short-term (3-year), mid-term (6-year) and long-term (10-year) objectives.

Funder

EPAnEk-NSRF

Publisher

F1000 Research Ltd

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Immunology and Microbiology,General Biochemistry, Genetics and Molecular Biology,General Medicine

Reference84 articles.

1. OMIM.org: leveraging knowledge across phenotype-gene relationships.;J Amberger;Nucleic Acids Res.,2019

2. Complex systems and population health: a primer.;Y Apostolopoulos,2020

3. ArrayExpress update - from bulk to single-cell expression data.;A Athar;Nucleic Acids Res.,2019

4. openBIS ELN-LIMS: an open-source database for academic laboratories.;C Barillari;Bioinformatics.,2016

5. Integrating Transcriptomic Data with Mechanistic Systems Pharmacology Models for Virtual Drug Combination Trials.;A Barrette;ACS Chem Neurosci.,2018

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. What’s next for computational systems biology?;Frontiers in Systems Biology;2023-09-19

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3